Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lixte Biotech Hlds (NQ: LIXT )

1.871 +0.071 (+3.95%)
Streaming Delayed Price Updated: 9:44 AM EDT, Aug 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lixte Biotech Hlds

< Previous 1 2 3 4 5 Next >
LIXT Stock Earnings: Lixte Biotech Hldgs Reported Results for Q2 2024
Lixte Biotech Hldgs just reported results for the second quarter of 2024. 
Via InvestorPlace
Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
LIXT Stock Earnings: Lixte Biotech Hldgs Reported Results for Q1 2024
Lixte Biotech Hldgs just reported results for the first quarter of 2024. 
Via InvestorPlace
Gold Moves Higher; Velo3D Shares Plummet
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining over 300 points on Wednesday. The Dow traded up 0.78% to 39,589.55 while the NASDAQ fell 0.02% to 16,312.74.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Edges Lower; PaySign Shares Spike Higher
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining over 200 points on Wednesday. The Dow traded up 0.56% to 39,502.25 while the NASDAQ fell 0.08% to 16,302.03. The S&P... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
Why Lixte Biotechnology Stock Is Soaring
The company announced the publication of pre-clinical data in the online journal, "Cancer Discovery", showing that its lead clinical compound, LB-100, can force cancer cells to give up their... 
Via Benzinga
Lixte Biotechnology Holdings Inc. (NASDAQ: LIXT) Near Top of Volume Charts in Wednesday Trading
Via Investor Brand Network
Dow Jumps Over 200 Points; UniFirst Posts Downbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.58% to 39,511.62 while the NASDAQ rose 0.60%... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
LIXT Stock Earnings: Lixte Biotech Hldgs Reported Results for Q4 2023
Lixte Biotech Hldgs just reported results for the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Kirkland's And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones closed lower by around 10 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Clearside Biomedical And 3 Other Stocks Under $3 Insiders Are Buying
The Dow Jones closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Exposures US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth checking out on Monday as we start off the week with all the latest news this morning! 
Via InvestorPlace
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 59 companies set new 52-week lows. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Celestica Shares Are Trading Higher By Over 42%; Here Are 20 Stocks Moving Premarket
Gainers Celestica Inc. (NYSE: CLS) shares surged 42.2% to $23.40 in pre-market trading after the company announced better-than-expected second-quarter results. 
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 56 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday morning, 70 companies achieved new lows for the year. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 54 companies hit new 52-week lows. 
Via Benzinga
Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77.... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. 
Via Benzinga
Dow Jumps Over 300 Points; Morgan Stanley Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 300 points on Tuesday. The Dow traded up 1% to 34,932.08 while the NASDAQ rose 0.34% to 14,293.55. The S&P 500, also... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.